Cargando…

Insights on common vaccinations in HIV-infection: efficacy and safety

HIV-infected patients are at increased risk for both vaccine-preventable diseases and their complications, with mortality rates higher than in non-HIV-infected individuals. Consequently, international guidelines generally recommend inactivated vaccines in HIV-patients, even if HIV-related immunodefi...

Descripción completa

Detalles Bibliográficos
Autores principales:	NICOLINI, L.A., GIACOBBE, D.R., DI BIAGIO, A., VISCOLI, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore SpA 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718346/ https://www.ncbi.nlm.nih.gov/pubmed/26789829

Ejemplares similares

Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection
por: Rosso, R, et al.
Publicado: (2009)

Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature
por: Mirabella, Michele, et al.
Publicado: (2018)

Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis
por: Delfino, Emanuele, et al.
Publicado: (2016)

Bloodstream infections in patients living with HIV in the modern cART era
por: Taramasso, L., et al.
Publicado: (2019)

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation
por: Cenderello, Giovanni, et al.
Publicado: (2015)

Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals
por: Nunes, Marta C., et al.
Publicado: (2012)

Cost-effectiveness analysis of initial HIV treatment under Italian guidelines
por: Colombo, Giorgio L, et al.
Publicado: (2011)

Safety and Efficacy of the Common Vaccines against COVID-19
por: Liu, Ying, et al.
Publicado: (2022)

Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS
por: Prinapori, Roberta, et al.
Publicado: (2015)

Epidemiology of bloodstream infections sustained by carbapenem-resistant Klebsiella pneumonia in a large teaching hospital in northern Italy
por: Alicino, C, et al.
Publicado: (2015)

Efficacy and safety of human papillomavirus vaccination in HIV-infected patients: a systematic review and meta-analysis
por: Zizza, Antonella, et al.
Publicado: (2021)

Tigecycline use in serious nosocomial infections: a drug use evaluation
por: Bassetti, Matteo, et al.
Publicado: (2010)

Is it still worthwhile to perform quarterly cd4+ t lymphocyte cell counts on hiv-1 infected stable patients?
por: Di Biagio, Antonio, et al.
Publicado: (2017)

A Global View to HBV Chronic Infection: Evolving Strategies for Diagnosis, Treatment and Prevention in Immunocompetent Individuals
por: Nicolini, Laura Ambra, et al.
Publicado: (2019)

Long-term efficacy and safety of raltegravir in the management of HIV infection
por: Liedtke, Michelle D, et al.
Publicado: (2014)

Vaccines and nephrotic syndrome: efficacy and safety
por: Angeletti, Andrea, et al.
Publicado: (2022)

Safety of live, attenuated oral vaccines in HIV-infected Zambian adults: Oral vaccines in HIV
por: Banda, Rose, et al.
Publicado: (2012)

Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study
por: Palacios, Rosario, et al.
Publicado: (2018)

Vaccine Production, Safety, and Efficacy
por: Brouwers, Thomas J., et al.
Publicado: (2021)

Safety of licensed vaccines in HIV-infected persons: a systematic review protocol
por: Kagina, Benjamin M, et al.
Publicado: (2014)

HIV and Co-Infections: Updates and Insights
por: Di Gennaro, Francesco, et al.
Publicado: (2023)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination
por: Bhorat, As’ad E., et al.
Publicado: (2015)

The Efficacy and Safety of Intralesional Immunotherapy with Measles, Mumps, Rubella Virus Vaccine for the Treatment of Common Warts in Adults
por: Chauhan, Pushpinder Singh, et al.
Publicado: (2019)

Raltegravir for HIV-1 infected children and adolescents: efficacy, safety, and pharmacokinetics
por: Larson, Kajal B, et al.
Publicado: (2013)

Safety and Efficacy of Ziagen (Abacavir Sulfate) in HIV-Infected Korean Patients
por: Ann, Heawon, et al.
Publicado: (2017)

General Practitioners as partners for a shared management of chronic HIV infection: An insight into the perspectives of Italian People Living with HIV
por: Bruno, Serena Rita, et al.
Publicado: (2021)

Safety and Immunogenicity of Measles Vaccination in HIV-Infected and HIV-Exposed Uninfected Children: A Systematic Review and Meta-Analysis
por: Mutsaerts, Eleonora A.M.L., et al.
Publicado: (2018)

Quality of life of people living with HIV, preliminary results from IANUA (Investigation on Antiretroviral Therapy) study
por: Venturini, Alberto, et al.
Publicado: (2014)

Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report
por: Di Biagio, Antonio, et al.
Publicado: (2009)

Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”
por: Nicolini, Laura Ambra, et al.
Publicado: (2020)

A Review of the Safety and Efficacy of Vaccines as Prophylaxis for Clostridium difficile Infections
por: Henderson, Mackenzie, et al.
Publicado: (2017)

Efficacy and safety of an NRTI-sparing regimen in antiretroviral-naïve HIV-infected patients: once-daily maraviroc plus lopinavir/ritonavir
por: Nozza, S, et al.
Publicado: (2010)

Prevalence and clinical impact of VIral Respiratory tract infections in patients hospitalized for Community-Acquired Pneumonia: the VIRCAP study
por: Tatarelli, P., et al.
Publicado: (2019)

Immunogenicity and safety of rapid scheme vaccination against tick-borne encephalitis in HIV-1 infected persons
por: Jilich, D., et al.
Publicado: (2021)

Reduced Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in Cardiac Surgery Patients after Implementation of an Antimicrobial Stewardship Project
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2019)

48-Week Efficacy and Safety of Dolutegravir Relative to Commonly Used Third Agents in Treatment-Naive HIV-1–Infected Patients: A Systematic Review and Network Meta-Analysis
por: Patel, Dipen A., et al.
Publicado: (2014)

Comparative efficacy, safety and durability of dolutegravir relative to common core agents in treatment-naïve patients infected with HIV-1: an update on a systematic review and network meta-analysis
por: Nickel, Katharina, et al.
Publicado: (2021)

Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of Liver
por: Roni, D. Ajith, et al.
Publicado: (2013)

Kidney Disease in HIV Infection
por: Alfano, Gaetano, et al.
Publicado: (2019)

Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohort
por: Nicolini, Laura Ambra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fepssbgsv93q0p9o9e21tmsvdm